AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06265194 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: EMDR
Description: The fibromyalgia protocol applied to the patients in the study was developed specifically for fibromyalgia by Konuk, and colleagues (Konuk et al.). In addition to the article, the details of the protocol and the study sheet are presented supplementary. After a short introduction, the participants were informed about the protocol, their -consent was obtained for registration, and a visual, tactile and audio bilateral stimulus that will be used in the application was introduced.
Study NCT06265194 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: TAU
Description: Treatment as Usual (TAU): Routine fibromyalgia treatments, referred to as Treatment as Usual (TAU) in this study, were initiated in the outpatient clinic conditions. TAU are treatments designed by rheumatologists in accordance with current rheumatology guidelines.
Study NCT06265194 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: TAU
Description: Treatment as Usual (TAU): Routine fibromyalgia treatments, referred to as Treatment as Usual (TAU) in this study, were initiated in the outpatient clinic conditions. TAU are treatments designed by rheumatologists in accordance with current rheumatology guidelines.
Study NCT04570787 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Urinary bladder catheterisation
Description: Installation of Foley catheter into the urinary bladder
Study NCT01589289 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Immunochromatographic HAT tests (DSD)
Description: Immunochromatographic HAT diagnostic tests manufactured by DSD, Korea and FIND
Study NCT01589289 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Card Agglutination Trypanosoma Test
Description: Card Agglutination Trypanosoma Test on whole blood and as dilution
Study NCT01589289 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: TB POC Nucleic Acid Amplification Test (Molbio Diagnostics)
Description: TB POC Nucleic Acid Amplification Test: microPCR handheld device (Molbio Diagnostics PVT ltd, India)
Study NCT01589289 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: TB 3-marker RDT (Tulip diagnostics)
Description: TB 3-marker RDT: ADA2/IFN-g/LAM (Tulip diagnostics, ltd, India) - pending availability for phase 3 validation
Study NCT01589289 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Cryptococcal Antigen Lateral Flow Assay (Immy)
Description: Cryptococcal Antigen Lateral Flow Assay (Immy, USA)
Study NCT03207386 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Youth VIP
Description: Youth VIP involves youth in partnerships with adults to adapt evidence based sexual violence prevention strategies for the local community environment. Youth VIP includes a three day intensive youth summit for prevention training and ongoing youth-adult prevention working groups.
Study NCT04315571 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Gore® Viatorr® Endoprosthesis with controlled expansion
Description: TIPS (Transjugular Intrahepatic Portosystemic Shunt) is a minimally invasive procedure in which a new path is made through the liver to carry blood from the portal vein to the heart, thus helping to alleviate the problems associated with elevated portal vein pressure.
Study NCT04315571 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Large Volume Paracentesis with albumin infusion
Description: For therapeutic (large-volume) paracentesis, a 14-gauge cannula attached to a vacuum aspiration system is used to collect up to 8 L of ascitic fluid. Concurrent infusion of IV albumin is recommended during large-volume paracentesis to help avoid significant intravascular volume shift and postprocedural hypotension.
Study NCT01091324 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dextromethorphan
Description: 60 mg, bid
Study NCT01091324 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Silymarin
Description: 150 mg , tid
Study NCT01091324 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: sugar pill
Description: placebo
Study NCT02254434 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Eltrombopag
Description: Eltrombopag 50 mg per tablet for oral route of administration will be sourced locally
Study NCT03925259 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy
Description: Acceptance and commitment therapy (ACT) is a 'third wave' behaviour therapy delivered on a one to one basis.
Study NCT03925259 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Acceptance and Commitment Therapy
Description: Acceptance and commitment therapy (ACT) is a 'third wave' behaviour therapy delivered on a one to one basis.
Study NCT01910246 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metformin
Study NCT02264912 — intervention group
Intervention type: DRUG
Intervention: antiplatelet drugs - P2Y12 antagonists
Study NCT01722422 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: oxygen and saline
Study NCT01722422 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: oxygen and saline
Study NCT02379572 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: iMRI-guided surgery
Description: For iMRI-guided glioma resections the surgery can be paused and a direct intraoperative resection control is possible by performing an intraoperative MRI scan. If residual tumor is found, the resection might be continued.
Study NCT02379572 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 5-ALA-guided surgery
Description: For 5-ALA guided glioma resections patients have to drink 100ml of a solution with 5-Aminolevulinic acid 4-6 hours before surgery. Intraoperatively the light source of the surgical microscope can be switched to a certain wave length to enable fluorescence of the glioma cells, which helps resecting the tumor as radical as possible.
Study NCT02337114 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Treatment as Usual
Description: A client-centred goal planning system linked to community reintegration and based on a holistic rehabilitation model including counselling, medical management, cognitive behavioural therapy and pharmacotherapy.
Study NCT02337114 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Treatment as Usual
Description: A client-centred goal planning system linked to community reintegration and based on a holistic rehabilitation model including counselling, medical management, cognitive behavioural therapy and pharmacotherapy.
Study NCT02207738 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: microneedling radiofrequency device
Description: Microneedling radiofrequency device is composed of 49 insulated microneedle which emit radiofrequency from the needle tip. This radiofreqeuncy generates dermal heat which evokes biological effect.
Study NCT02207738 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: bipolar radiofrequency
Description: bipolar radiofrequency instrument gives out bipolar radiofrequency from the hand piece tip. This bipolar radiofrequency generates dermal heat which has a lot of bilogical effect.
Study NCT01226407 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CG200745
Description: Multiple administration (IV) over the cycles untile MTD/LTD
Study NCT02032797 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Progesterone
Study NCT02032797 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Progesterone
Study NCT01937949 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Custom-made Zenith® Fenestrated AAA Endovascular Graft:
Description: The graft will be inserted through arteries in the groin (called endovascular repair). Endovascular repair is a procedure that uses catheters that go inside your blood vessel to place a stent graft above and below the aneurysm. This procedure lines the aneurysm with a new lining (stent) so blood does not fill the artery any more.
Study NCT02492542 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PHENIX USB 8.
Description: Electrical stimulation program: frequency: 1/4/Hertz (HZ), pulse width: 270/230/270 μs, time: 30min. Electrode piece: 50\*50mm sticky electrode plate. Position: an electrode piece is placed in the S3, and an electrode piece is placed in the bladder region.Current intensity adjusted according to the patient's tolerance, the maximum current intensity of the pain was not appropriate, generally not more than 100milliampere(mA).Devices PHENIX USB 8.
Study NCT00898950 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aspirin
Description: Aspirin 75mgs/day orally for 2 weeks.
Study NCT00898950 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aspirin
Description: 300mgs/day orally for 2 weeks
Study NCT00898950 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aspirin
Description: aspirin 900mgs QID orally for 2 weeks
Study NCT00898950 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: placebo tablet
Description: placebo tablet with lactose and excipients.
Study NCT01235494 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: polarised 3 helium
Description: 1 inhalation (= 1 litre)
Study NCT02002637 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Latella Knee Implant System
Study NCT02297204 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Focal Laser Treatment
Description: All subjects receiving PRN IVT aflibercept injections will be evaluated for focal laser treatment beginning at week 12 through the end of the study. If the subject meets any of the criteria for focal laser treatment (FLT), fluorescein angiography (FA) will be performed to guide the focal laser treatment. Focal laser treatment and focal laser re-treatment will be administered no more than once every 90 days.
Study NCT02297204 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: aflibercept 2.0 mg
Description: If a subject has recurrent CR-DME they will receive an IVT aflibercept injection
Study NCT02439866 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: gelatinous capsules filled with sugar as placebo
Study NCT02439866 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Intravenous methylprednisolone
Description: Intravenous methylprednisolone (Solu-Medrol, Pharmacia Pharmaceutical Company, Belgium) 500 mg twice a day for 3 days followed by 2 weeks of oral prednisolone 1mg/kg/day (Prednisolone Fort; Sina Daroo, Iran
Study NCT02439866 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: normobaric oxygen with face mask
Description: normobaric oxygen100% with face mask in sitting position, at a flow rate of 5 liters per minute for 1 hour twice a day for two weeks
Study NCT03784105 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Codeine Phosphate
Description: 30 mL of codeine phosphate 10mg/5mL
Study NCT00722735 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Finafloxacin
Description: Finafloxacin tablets, 300 mg b.i.d., oral administration; Ciprofloxacin placebo capsule, 1 capsule b.i.d.,oral administration; duration: 3 days
Study NCT00722735 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ciprofloxacin
Description: Finafloxacin placebo, 6 tablets b.i.d., oral administration; Ciprofloxacin capsule, 250 mg b.i.d., oral administration; duration: 3 days
Study NCT00002494 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cyclophosphamide
Study NCT00002494 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cytarabine
Study NCT00002494 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: dexamethasone
Study NCT00002494 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: doxorubicin hydrochloride
Study NCT03784105 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Siripus simplex
Description: Sugar syrup
Study NCT04873206 — intervention group
Intervention type: OTHER
Intervention: routine stain by H&E.
Description: formalin fixed, Parraffin embedded endometrial tissues will be sectioned and get stained by the routine Haematoxalin and Eosin stain in addition to immunohistochemical staining by anti-human PTEN antibody.
Study NCT02424474 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Genetic NIPT
Description: Both tests are realized in a population of pregnant women (with and without in vitro fertilisation (IVF)) concomitantly at the same time.
Study NCT02424474 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Regular serum screening
Study NCT00223756 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Low Vision Intervention - Outpatient Training Program
Description: Patients receive LV therapy as outpatients
Study NCT03018067 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RDX227675
Study NCT00002494 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: etoposide
Study NCT03018067 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT01484743 — intervention group
Intervention type: PROCEDURE
Intervention: differences in surgical techniques
Description: follow the risk for morbidity after incisional hernia repair
Study NCT04792762 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: GIP(1-30)NH2
Description: Intravenous administration of the peptide hormone GIP(1-30)NH2 during a stepwise glucose clamp
Study NCT04792762 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: GIP(1-42)
Description: Intravenous administration of the peptide hormone GIP(1-42) during a stepwise glucose clamp
Study NCT04792762 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Saline
Description: Intravenous administration of saline during a stepwise glucose clamp
Study NCT00576446 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Dendritic cell Vaccine
Description: Patients will receive three vaccines every two weeks
Study NCT01686230 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: acupuncture
Description: In each session, we treat bilaterally, 3 times a week and 2 days off a week, each patient in the acupuncture treatment groups will receive 12 sessions of acupuncture treatment over 4 weeks. The whole study period is 20 weeks including 4-week baseline period,4-week treatment period, and 12-week follow-up period. we will investigate at 0 day,4week,8week,12week,16week after randomization。
Study NCT01686230 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: acupuncture
Description: In each session, we treat bilaterally, 3 times a week and 2 days off a week, each patient in the acupuncture treatment groups will receive 12 sessions of acupuncture treatment over 4 weeks. The whole study period is 20 weeks including 4-week baseline period,4-week treatment period, and 12-week follow-up period. we will investigate at 0 day,4week,8week,12week,16week after randomization。
Study NCT01686230 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: acupuncture
Description: In each session, we treat bilaterally, 3 times a week and 2 days off a week, each patient in the acupuncture treatment groups will receive 12 sessions of acupuncture treatment over 4 weeks. The whole study period is 20 weeks including 4-week baseline period,4-week treatment period, and 12-week follow-up period. we will investigate at 0 day,4week,8week,12week,16week after randomization。
Study NCT01686230 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Basic treatment
Description: Each group in the basic treatment，Foundation treatment including health education and basic drug therapy.~We recommend lifestyle modification for all patients. Modifications include increasing exercise; limiting alcohol consumption; and weight loss; quit smorking etc.~Basic medication： Aspirin: 100mg qd; Metoprolol：25mg bid; Ramipril:5mg qd; Atorvastatin:20mg qn.
Study NCT01686230 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Basic treatment
Description: Each group in the basic treatment，Foundation treatment including health education and basic drug therapy.~We recommend lifestyle modification for all patients. Modifications include increasing exercise; limiting alcohol consumption; and weight loss; quit smorking etc.~Basic medication： Aspirin: 100mg qd; Metoprolol：25mg bid; Ramipril:5mg qd; Atorvastatin:20mg qn.
Study NCT01686230 — intervention group
Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: Basic treatment
Description: Each group in the basic treatment，Foundation treatment including health education and basic drug therapy.~We recommend lifestyle modification for all patients. Modifications include increasing exercise; limiting alcohol consumption; and weight loss; quit smorking etc.~Basic medication： Aspirin: 100mg qd; Metoprolol：25mg bid; Ramipril:5mg qd; Atorvastatin:20mg qn.
Study NCT01686230 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Basic treatment
Description: Each group in the basic treatment，Foundation treatment including health education and basic drug therapy.~We recommend lifestyle modification for all patients. Modifications include increasing exercise; limiting alcohol consumption; and weight loss; quit smorking etc.~Basic medication： Aspirin: 100mg qd; Metoprolol：25mg bid; Ramipril:5mg qd; Atorvastatin:20mg qn.
Study NCT02558530 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Low carbohydrate diet
Description: Isocaloric, carbohydrate restricted diet 14 days
Study NCT01038297 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EXC 001
Description: Intradermal injections of EXC 001 and placebo given on various schedules.
Study NCT01038297 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Intradermal injections of EXC 001 and placebo given on various schedules.
Study NCT03857269 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Acupoint Massage
Description: The operators is trained for two weeks. At 9 o'clock in the morning, the elderly are organized by Nursing home to perform acupressure.Intervention frequency will be monday to saturday per week for 6 months.
Study NCT03857269 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: lavender essential oil
Description: Modulated by an international aroma therapist,The cotton ball containing essential oil is replaced by the operator at 9 am.Intervention frequency will be monday to saturday per week for 6 months.
Study NCT03857269 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Acupoint Massage and lavender essential oil
Description: At the same time as the acupressure, patients began to smell the essential oil.Intervention frequency will be monday to saturday per week for 6 months.
Study NCT00933647 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Yerba Mate Tea
Description: Before and after 8 weeks, serum lipids, C-reactive protein and fibrinogen will be measured. They will also be tested for glycemia, insulin, aminotransferases, bilirubin. Anthropometric measurements will be also performed at week 0 and 8. The subjects will receive instructions to maintain their usual dietary intake and normal physical activity.
Study NCT00933647 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Green tea
Description: Before and after 8 weeks, serum lipids, C-reactive protein and fibrinogen will be measured. They will also be tested for glycemia, insulin, aminotransferases, bilirubin. Anthropometric measurements will be also performed at week 0 and 8. The subjects will receive instructions to maintain their usual dietary intake and normal physical activity.
Study NCT04015583 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: exergaming group
Description: Exergame is 'exercise + game'. Treadmill exercise is traiditional aerobic exercise
Study NCT04209114 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Nivolumab
Description: Specified dose on specified days
Study NCT00933647 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Apple tea
Description: Before and after 8 weeks, serum lipids, C-reactive protein and fibrinogen will be measured. They will also be tested for glycemia, insulin, aminotransferases, bilirubin. Anthropometric measurements will be also performed at week 0 and 8. The subjects will receive instructions to maintain their usual dietary intake and normal physical activity.
Study NCT04079465 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: O2matic
Description: O2matic controls oxygen supply with a closed-loop feedback from a pulse oximeter. The aim is to maintain SpO2 within a predefined target interval according to guidelines for the specific condition causing hypoxemia, with the lowest possible supplementation of oxygen.
Study NCT03267901 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: food
Description: 45 g of walnut / iso-caloric white bread
Study NCT00993421 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY377604
Description: Given daily, orally for 24 weeks
Study NCT00993421 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sibutramine
Description: given daily, orally for 24 weeks
Study NCT00993421 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sibutramine
Description: given daily, orally for 24 weeks
Study NCT00993421 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Metoprolol
Description: given daily, orally for 24 weeks (100 mg for 1 week followed by 200 mg for 23 weeks. Patients unable to tolerate 200 mg will be dose reduced to 100 mg), followed by a 2 week taper (1 week at 100 mg/day followed by 1 week at 50 mg/day).
Study NCT00993421 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo sibutramine
Description: given daily, orally for 24 weeks
Study NCT00993421 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo sibutramine
Description: given daily, orally for 24 weeks